S
Saskia Ingen-Housz-Oro
Researcher at Paris 12 Val de Marne University
Publications - 269
Citations - 4346
Saskia Ingen-Housz-Oro is an academic researcher from Paris 12 Val de Marne University. The author has contributed to research in topics: Medicine & Toxic epidermal necrolysis. The author has an hindex of 28, co-authored 217 publications receiving 3220 citations. Previous affiliations of Saskia Ingen-Housz-Oro include Pasteur Institute & Centre hospitalier universitaire Henri-Mondor.
Papers
More filters
Journal ArticleDOI
First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial.
Pascal Joly,Maud Maho-Vaillant,Catherine Prost-Squarcioni,Vivien Hébert,Estelle Houivet,Sébastien Calbo,Frédérique Caillot,Marie-Laure Golinski,Bruno Labeille,Catherine Picard-Dahan,Carle Paul,Marie-Aleth Richard,Jean-David Bouaziz,Sophie Duvert-Lehembre,Philippe Bernard,Frédéric Caux,Marina Alexandre,Saskia Ingen-Housz-Oro,Pierre Vabres,Emmanuel Delaporte,Gaëlle Quéreux,Alain Dupuy,Sébastien Debarbieux,Martine Avenel-Audran,Michel D'Incan,Christophe Bedane,Nathalie Beneton,Denis Jullien,Nicolas Dupin,Laurent Misery,Laurent Machet,Marie Beylot-Barry,Olivier Dereure,Bruno Sassolas,Thomas Vermeulin,Jacques Benichou,P. Musette +36 more
TL;DR: Data from this trial suggest that first-line use of rituximab plus short-termprednisone for patients with pemphigus is more effective than using prednisone alone, with fewer adverse events.
Journal ArticleDOI
Risk Factors for Bullous Pemphigoid in the Elderly: A Prospective Case–Control Study
Sylvie Bastuji-Garin,Pascal Joly,Pauline Lemordant,Agnès Sparsa,Christophe Bedane,Emmanuel Delaporte,Jean-Claude Roujeau,Philippe Bernard,Jean-Claude Guillaume,Saskia Ingen-Housz-Oro,Hervé Maillard,Catherine Pauwels,Catherine Picard-Dahan,Yes Dutronc,Marie-Aleth Richard +14 more
TL;DR: Risk factors for BP include neurological disorders, particularly dementia and Parkinson's disease, psychiatric disorders (unipolar and bipolar disorders), bedridden condition, and chronic use of several drugs.
Journal ArticleDOI
Long-Term Remissions of Severe Pemphigus After Rituximab Therapy Are Associated with Prolonged Failure of Desmoglein B Cell Response
Natacha Colliou,Damien Picard,Frédérique Caillot,Sébastien Calbo,Stéphanie Le Corre,Annick Lim,Brigitte Lemercier,Brigitte Le Mauff,Maud Maho-Vaillant,Serge Jacquot,Christophe Bedane,Philippe Bernard,Frédéric Caux,Catherine Prost,Emmanuel Delaporte,Marie-Sylvie Doutre,Brigitte Dréno,Nathalie Franck,Saskia Ingen-Housz-Oro,Olivier Chosidow,Christine Pauwels,Catherine Picard,Jean-Claude Roujeau,M.-L. Sigal,E. Tancrede-Bohin,Isabelle Templier,Rüdiger Eming,Michael Hertl,Michel D'Incan,Pascal Joly,Philippe Musette +30 more
TL;DR: It is found that rituximab therapy can help pemphigus patients even after 6 years, in part by reshaping the B cell repertoire during reconstitution, allowing for long-term effects in addition to the short-term loss of pathogenic B cells.
Journal ArticleDOI
Low Blood Concentration of Hydroxychloroquine in Patients With Refractory Cutaneous Lupus Erythematosus: A French Multicenter Prospective Study
Camille Francès,Anne Cosnes,Pierre Duhaut,Noël Zahr,Boutros Soutou,Saskia Ingen-Housz-Oro,Didier Bessis,Jacqueline Chevrant-Breton,Nadège Cordel,Dan Lipsker,Nathalie Costedoat-Chalumeau +10 more
TL;DR: In this paper, the relation between blood concentration of hydroxychloroquine and clinical efficacy of hydroxyl chloroquine sulfate in a series of patients with cutaneous lupus erythematosus (CLE) was studied.
Journal ArticleDOI
Systemic involvement of acute generalized exanthematous pustulosis: a retrospective study on 58 patients
Claire Hotz,Laurence Valeyrie-Allanore,C. Haddad,Sophie Bouvresse,Nicolas Ortonne,Tu Anh Duong,Saskia Ingen-Housz-Oro,J.-C. Roujeau,Pierre Wolkenstein,Olivier Chosidow,Olivier Chosidow +10 more
TL;DR: Acute generalized exanthematous pustulosis (AGEP) is a severe cutaneous adverse reaction characterized by rash with sterile pustules, high fever and elevated circulating neutrophil counts.